tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market

Intellia Therapeutics (NTLA) Technical Analysis

Compare
3,407 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Intellia Therapeutics’s (NTLA) Moving Averages Convergence Divergence (MACD) indicator is -0.22, suggesting Intellia Therapeutics is a Buy.
Intellia Therapeutics’s (NTLA) 20-Day exponential moving average is 10.51, while Intellia Therapeutics’s (NTLA) share price is $9.1, making it a Sell.
Intellia Therapeutics’s (NTLA) 50-Day exponential moving average is 11.34, while Intellia Therapeutics’s (NTLA) share price is $9.1, making it a Sell.

Intellia Therapeutics (NTLA) Pivot Points

Mar 05, 2025, 04:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.11
8.74
9.10
9.73
10.09
10.72
11.07
Fibonacci
8.74
9.12
9.36
9.73
10.11
10.34
10.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Intellia Therapeutics (NTLA) Moving Averages

Mar 05, 2025, 04:42 PM
Period
Simple
Exponential
MA5
10.06Sell
9.90Sell
MA10
10.92Sell
10.32Sell
MA20
10.47Sell
10.51Sell
MA50
10.83Sell
11.34Sell
MA100
13.42Sell
13.44Sell
MA200
18.29Sell
17.50Sell
Intellia Therapeutics’s (NTLA) 10-Day exponential moving average is 10.32, while Intellia Therapeutics’s (NTLA) share price is $9.1, making it a Sell.
Intellia Therapeutics’s (NTLA) 100-Day exponential moving average is 13.44, while Intellia Therapeutics’s (NTLA) share price is $9.1, making it a Sell.
Intellia Therapeutics’s (NTLA) stock price is $9.1 and Intellia Therapeutics’s (NTLA) 50-day simple moving average is 10.83, creating a Sell signal.
Intellia Therapeutics’s (NTLA) stock price is $9.1 and Intellia Therapeutics’s (NTLA) 100-day simple moving average is 13.42, creating a Sell signal.
Intellia Therapeutics’s (NTLA) stock price is $9.1 and Intellia Therapeutics’s (NTLA) 200-day simple moving average is 18.29, creating a Sell signal.

Intellia Therapeutics (NTLA) Technical Indicators

Mar 05, 2025, 04:42 PM
Name
Value
Implied Action
RSI (14)
36.69
Neutral
STOCH (9,6)
12.31
Buy
STOCHRSI (14)
19.79
Buy
MACD (12,26)
-0.22
Buy
ADX (14)
17.08
Buy
Williams %R
-82.38
Buy
CCI (14)
-114.47
Buy
ATR (14)
0.92
-
Ultimate Oscillator
35.37
Neutral
ROC
-1.19
Sell
Intellia Therapeutics’s (NTLA) Relative Strength Index (RSI) is 36.69, creating a Neutral signal.
Intellia Therapeutics’s (NTLA) Trend Strength Indicator (ADX) is 17.08, creating a Buy signal.
Intellia Therapeutics’s (NTLA) Commodity Channel Index (CCI) is -114.47, creating a Buy signal.
Intellia Therapeutics’s (NTLA) Price Rate of Change (ROC) is -1.19, creating a Sell signal.

FAQ

Is NTLA a Buy, Hold, or Sell?
Based on NTLA’s technical indicators, NTLA is a Sell.
    What is NTLA’s RSI (14)?
    NTLA’s RSI (14) is 36.69, which suggests NTLA is a Neutral.
      What is NTLA’s MACD?
      NTLA’s MACD is -0.22, which suggests NTLA is a Buy.
        What is NTLA’s 5-day moving average?
        NTLA’s 5-day moving average is 10.06, which suggests NTLA is a Sell.
          What is NTLA’s 20-day moving average?
          NTLA 20-day moving average is 10.47, which suggests NTLA is a Sell.
            What is NTLA’s 50-day moving average?
            NTLA’s 50-day moving average is 10.83, which suggests NTLA is a Sell.
              What is NTLA’s 200-day moving average?
              NTLA’s 200-day moving average is 18.29, which suggests NTLA is a Sell.
                What is NTLA’s Williams % R (14)?
                NTLA’s Williams % R (14) is -82.38, which suggests NTLA is a Buy.
                  What is NTLA’s CCI (14)?
                  NTLA’s CCI (14) is -114.47, which suggests NTLA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis